Showing results (151-160 of 315) with videos related to
Sort By:
Pageof 32
Cancer|November 15, 1996
Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapyF O Recio, M S Piver, R E Hempling, et al.Gynecologic Oncology|June 1, 2000
Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient miceD F Silver, R E Hempling, M S Piver, et al.Gynecologic Oncology|December 1, 1996
Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancerJ M Goldberg, M S Piver, R E Hempling, et al.Cancer|January 15, 1980
Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinomaM S Piver, J J Barlow, J R Lurain, et al.European Journal of Gynaecological Oncology|January 1, 1994
Lack of activity of 5-fluorouracil plus mitomycin-C as salvage therapy in cisplatin-resistant epithelial ovarian cancer: results of a phase II trialR E Hempling, M S Piver, T R Baker, et al.Gynecologic Oncology|February 18, 1999
Palliative sclerosis of intra-abdominal cystic ovarian or peritoneal carcinomaP G Rose, V BasileGynecologic Oncology|October 19, 2001
Improved therapeutic index of lower dose topotecan chemotherapy in recurrent ovarian cancerM Rodriguez, P G RoseGynecologic Oncology|February 1, 1994
Advanced cervical carcinoma presenting with toxic shock syndromeP G Rose, G WilsonObstetrics and Gynecology|June 1, 1997
Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control studyR E Hempling, C Wong, M S Piver, et al.Gynecologic Oncology|March 1, 1988
Serum alpha 1-acid glycoprotein in epithelial ovarian cancerM S Piver, M Moyer, K Diakun, et al.Pageof 32